Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,833 | -15,141 | -6,718 | -25,504 | -19,157 |
| Depreciation Amortization | 12 | 8 | 4 | 17 | 13 |
| Accounts payable and accrued liabilities | 2,853 | 1,331 | 486 | -127 | 755 |
| Other Working Capital | 2,455 | 556 | 192 | 448 | 1,934 |
| Other Operating Activity | -710 | 28 | 77 | 4,136 | 2,476 |
| Operating Cash Flow | $-19,223 | $-13,218 | $-5,959 | $-21,030 | $-13,979 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -9 | -9 | -19 | -19 |
| Investing Cash Flow | $-16 | $-9 | $-9 | $-19 | $-19 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 3,673 | 304 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $3,673 | $304 |
| Beginning Cash Position | 71,194 | 71,194 | 71,194 | 88,570 | 88,570 |
| End Cash Position | 51,955 | 57,967 | 65,226 | 71,194 | 74,876 |
| Net Cash Flow | $-19,239 | $-13,227 | $-5,968 | $-17,376 | $-13,694 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,223 | -13,218 | -5,959 | -21,030 | -13,979 |
| Capital Expenditure | -16 | -9 | -9 | -19 | -19 |
| Free Cash Flow | -19,239 | -13,227 | -5,968 | -21,049 | -13,998 |